Extracorporeal affinity therapy

Ekstrakorporal tedaviler bilirubin, patojenik antibadiler, dolaşımdaki çeşitli immün kompleksler, kolesterol, toksik metal iyonları gibi olası toksik maddelerin insan plazmasından uzaklaştırılmasına yöneliktir. Plazma değişimi, hemodiyaliz, hemofiltrasyon ve hemoperfüzyonu içeren geleneksel ekstrakorporal tedaviler seçici olmayan yöntemlerdir. Ayrıca, albümin gibi plazma desteklerine olan ihtiyaç oldukça fazladır. Dahası, plazma ve plazma destekleri kullanılırken hepatit veya immün reaksiyonların ortaya çıkma tehlikesi bulunmaktadır. Günümüzde ekstrakorporal tedavinin en umut verici uygulaması spesifik afinite adsorpsiyonudur. Afinite taşıyıcılar, kanın bu taşıyıcılarla doldurulmuş kolondan doğrudan geçirildiği hemoperfüzyon sisteminde kullanılabilir. Bu tür uygulama etkili, basit ve ucuzdur. Bu derlemede, ekstrakorporal tedavinin insan plazmasından toksik maddelerin uzaklaştırılması için kullanıldığı bazı ilginç uygulamalar kısaca verilmiştir.

Ekstrakorporal afinite tedavisi

Extracorporeal therapies are directed at the removal of potential toxic substances including bilirubin, pathogenic antibodies, various circulating immune-complexes, cholesterol, toxic metal ions, etc. from human plasma. The conventional extracorporeal therapies including plasma exchange, hemodialysis, hemofiltration and hemoperfusion are non-selective techniques. In addition the requirement for plasma substitutes such as albumin is very high. Moreover, the dangers of hepatitis or immune reactions accompany these therapies while using plasma for plasma products. Today, one of the most promising procedures for extracorporeal therapy is specific affinity adsorption. Affinity carriers may be used in hemoperfusion system, where blood is directly perfused through the column filled with these carriers. This type of application is effective, simple and inexpensive. In this article, some interesting applications on extracorporeal affinity therapies for removal of toxic substances from human plasma are briefly reviewed.

PDF

___

1. E. Pişkin, A.S. Hoffman, Polymeric Biomaterials, NATO ASI Series, Martinus Nijhoff Publishers, Dordrecht, 1986.
2. S. Xia, N. Hodge, M. Laski, T.F. Wiesner, Middle molecule uremic toxin removal via hemodialysis augmented with an immunosorbent packed bed, Ind. Eng. Chem. Res., 49 (2010) 1359.
3. E. Behm, P. Ivanovich, H. Klinkmann, Selective and specific adsorbents for medical therapy, Int. J. Artif. Organs, 12 (1989) 1.
4. Y. Takenaka, Bilirubin adsorbent column for plasma perfusion, Therapeutic Apheresis, 2 (1998) 129.
5. K.H. Lee, J. Wendon, M. Lee, M.D. Costa, S.G. Lim, K.C. Tan, Predicting the decrease of conjugated bilirubin with extracorporeal albumin dialysis MARS using the predialysis molar ratio of conjugated bilirubin to albumin, Liver Transplantation, 8 (2002) 591.
6. J.D. Ostrow, Bile Pigments and Jaundice: Molecular, Metabolic and Medical Aspects, New York, Dekker, 1986.
7. C. Tiribelli, J.D. Ostrow, The molecular basis of bilirubin encephalopathy and toxicity, J. Hepatology, 43 (2005) 156.
8. X.X. Zhu, G.R. Brown and L.E. St-Pierre, Adsorption of bilirubin with polypeptide-coated resin, Biomat. Artif. Cells, Artif. Organs, 18 (1990) 75.
9. S. Sideman, L. Mor, D. Mordohovich, M. Mihich, O. Zinder and J.M. Brandes, In vivo hemoperfusion studies of unconjugated bilirubin removal by ion exchange resin, Trans. Am. Soc. Artif. Intern. Organs, 27 (1981) 434.
10. Y. Idezuki, M. Hamaguchi, S. Hamabe, H. Moriya, T. Nagashima, H. Watanabe, T. Sonoda, K. Teramoto, T. Kikuchi, H. Tanzawa, Removal of bilirubin and bile acid with a new anion exchange resin, Trans Am. Soc. Artif. Intern. Organs, 27 (1981) 428.
11. G.R. Brown, Oligo-peptide functionalized polymeric sorbents for bilirubin, Int. J. Biochromatogr., 1 (1994) 73.
12. T. Chandy, C.P. Sharma, Polylysine immobilized chitosan beads as adsorbents for bilirubin, Artif. Organs, 16 (1992) 568.
13. Z. Yamazaki, N. Inoue, T. Wada, T. Oda, K. Atsumi, K. Kataoka and Y. Fujisaki, Use of an AR-1 resin column to reduce bilirubin level in modified ascitic fluid, Trans. Am. Soc. Artif. Intern. Organs, 25 (1979) 480.
14. T. Morimoto, M. Matsushima, N. Sowa, K. Ide and S. Sawanishi, Plasma adsorption using bilirubinadsorbent materials as a treatment for patients with hepatic failure, Artif. Organs, 13 (1989) 447.
15. M.E. Avramescu, W.F.C. Sager, Z. Borneman, M. Wessling, Adsorptive membranes for bilirubin removal, J. Chromatogr. B., 803 (2004) 215.
16. Y. Yu, B. He, H. Gu, Adsorption of bilirubin by aminecontaining crosslinked chitosan resin, Artif. Cells Blood Subs. Immob. Biotech., 28 (2000) 307.
17. H. Kuroda, T. Ranaka, Z. Osawa, Selective adsorption of bilirubin by macroporous poly(GMA-DVB) beads, Die Angew. Makromol Chem, 237 (1996) 143.
18. N. Ahmad, K. Arif, S.M. Faisal, M.K. Neyaz, S. Tayyab, M. Owais, PGLA-microsphere mediated clearance of bilirubin in temporarily hyperbilirubinemic rats, Biochim. Biophys. Acta, 1760 (2006) 227.
19. A. Denizli, M. Kocakulak, E. Pişkin, Bilirubin removal from human plasma in a packed bed column system with dye-affinity beads, J. Chromatogr. B, 707 (1998) 25.
20. M. Kocakulak, A. Denizli, A.Y. Rad, E. Pişkin, New sorbent for bilirubin removal from human plasma: cibacron blue-immobilized poly(EGDMA-HEMA) beads, J. Chromatogr. B., 693 (1997) 271.
21. A. Denizli, E. Pişkin, Dye-ligand affinity systems, J. Biochem. Biophys. Methods, 49 (2001) 391.
22. A. Denizli, M. Kocakulak, E. Pişkin, Alkali blue 6B-derivatized poly(EGDMA-HEMA) beads for bilirubin removal from human plasma, J. Macromol. Sci. Pure Appl. Chem., A35 (1998) 137.
23. A. Denizli, M. Kocakulak, E. Pişkin, Specific sorbents for bilirubin removal from human plasma: congo red modified poly(EGDMA-HEMA) beads, J. Appl. Polym. Sci., 68 (1998) 373.
24. A. Kassab, H. Yavuz, M. Odabaşı, A. Denizli, Human serum albumin chromatography by cibacron blue F3GA-derived microporous polyamide hollow fibre membranes, J. Chromatogr B, 746 (2000) 123.
25. S. Şenel, F. Denizli, H. Yavuz, A. Denizli, Bilirubin removal from human plasma by dye affinity microporous hollow fibers, Sep. Sci. Technol., 37 (2002) 1989.
26. L. Uzun, A. Denizli, Bilirubin removal performance of immobilized albumin in a magnetically stabilized fluidized bed, J. Biomater. Sci. Polym. Ed., 17 (2006) 791.
27. T. Peters, All about albumin, Biochemistry, Genetics and Medical Applications, New York, Academic Press, 1996.
28. A.Y. Rad, H. Yavuz, M. Kocakulak, A. Denizli, Bilirubin removal from human plasma with albumin immobilized magnetic poly(hydroxyethyl methacrylate) beads, Macromol. Biosci., 3 (2003) 471.
29. B. Xia, G. Zhang, F. Zhang, Bilirubin removal by Cibacron Blue F3GA attached nylon-based hydrophilic affinity membrane, J. Membr. Sci., 226 (2003) 9.
30. C.R. Davies, P.S. Malchesky and G.M. Saide, Temperature and albumin effects on adsorption of bilirubin from standard solution using anionexchange resin, Artif Organs, 14 (1990) 14.
31. L. Zhang, G. Jin, Bilirubin removal from human plasma by Cibacron Blue F3GA using immobilized microporous affinity membranaus capillary method, J. Chromatogr. B., 821 (2005) 112.
32. D.S. Henning, G.R. Brown and L.E. St-Pierre, Polymer resins with amino acid containing pendants for sorption of bilirubin, Int. J. Artif. Organs, 9 (1986) 33.
33. F. Kanai, T. Takahama, I. Iizuka, M. Hiraishi, Z. Yamazaki, Y. Fujimori, Y. Maruyama, T. Wada, K. Asano, T. Sonoda, Artificial Organs, 9 (1985) 75.
34. I.A. Chernova, K.Y. Gurevich, Structure and sorption characteristics of bioaffinity membranes, J. Membr. Sci., 113 (1996) 161.
35. C. Alvarez, M. Strumia, H. Bertorello, Influence of the polymeric morphology of sorbents on their properties in affinity chromatography, J. Biochem. Biophys. Methods, 49 (2001) 649.
36. H. Wang, J. Ma, Y. Zhang, B. He, Adsorption of bilirubin on the polymeric b-cyclodextrin supported by partially aminated polyacrylamide gel, React. Functl. Polym., 32 (1997) 1.
37. Z. Ma, M. Kotaki, S. Ramakrishna, Electrospun cellulose nanofiber as affinity membrane, J. Membr. Sci., 265 (2004) 155.
38. W. Shi, F. Zhang, G. Zhang, Adsorption of bilirubin with polylysine carrying chitosan-coated nylon affinity membranes, J. Chromatogr. B., 819 (2005) 301.
39. W. Shi, F. Zhang, G. Zhang, D. Ge, Q. Zhang, Adsorption of bilirubin on poly-L-lysine containing nylon membranes, Polym. Int., 54 (2005) 790.
40. B. Gao, H. Lei, L. Jiang, Y. Zhu, Studies on preparing and adsorption property of grafting terpolymer microbeads of PEI-GMA/AM/MBA for bilirubin, J. Chromatogr. B., 853 (2007) 62.
41. L. Zhang. G. Jin, New sorbent for bilirubin removal from human plasma, Chinese Chem. Lett., 16 (2005) 1495.
42. X.Y. Han, Z.P. Zhang, Preparation of grafted polytetrafluoroethylene fibers and adsorption of bilirubin, Polym. Int., 58 (2009) 1126.
43. W. Shi, Y. Shen, H. Jiang, C. Song, Y. Ma, J. Mu, B. Yang, D. Ge., Lysine-attached anodic aluminum oxide-silica affinity membrane for bilirubin removal, J. Membr. Sci., 349 (2010) 333.
44. W. Shi, H. Cao, C. Song, H. JIang, J. Wang, S. Jiang, J. Tu, D. Ge, Poly(pyrrole-3-carboxylic acid) alumina composite membrane for affinity adsorption of bilirubin, J. Membr. Sci., 353 (2010) 151.
45. E.B. Altıntaş, D. Türkmen, V. Karakoç, A. Denizli, Efficient removal of bilirubin from human serum by monosize dye-affinity beads, J. Biomater. Sci., 22 (2011) 957.
46. K. Takeda, A. Kuwahara, K. Ohmon, T. Takeuchi, Molecularly imprinted tunable binding sites based on conjugated prosthetic groups and ion-paired cofactors, J. Am. Chem. Soc., 131 (2009) 8833.
47. B. Sellergren (Ed), Molecularly imprinted polymers: man-made mimics of antibodies and their application in analytical chemistry. Elsevier, Amsterdam (2001).
48. T. Mori, K. Okamoto, H. Endo, J.P. Hill, S. Shinoda, M. Matsukara, H. Tsukube, Y. Suzuki, Y. Kanekiyo, K. Ariga, Mechanical tuning of molecular recognition to discriminate the single-methyl group difference between thymine and uracil, J. Am. Chem. Soc., 2011, in press.
49. Y. Ge, A.P.F. Turner, Too large to fit ? Recent developments in macromolecular imprinting, Trends in Biotechnol., 26 (2008) 4.
50. M. Tatemichi, M.A. Sakamoto, M. Mizuhata, S. Deki, T. Takeuchi, Protein templated organic/inorganic hybrid materials prepared by liquid-phase deposition, J. Am. Chem. Soc., 129 (2007) 10906.
51. T. Takeuchi, T. Hishiya, Molecular imprinting of proteins emerging as a tool for protein recognition, Org. Biomol. Chem., 6 (2008) 2459.
52. S. Büyüktiryaki, R. Say, A. Ersöz, E. Birlik, A. Denizli, A., Selective preconcentration of thorium in the presence of UO2 2+, Ce3+ and La3+ using Th4+ Imprinted Polymer, Talanta, 67 (2005) 640.
53. K. Takeda, A. Kuwahara, K. Ohmori, T. Takeuchi, Molecularly imprinted tunable binding sites based on conjugated prosthetic groups and ion-paired cofactors, J. Am. Chem. Soc., 131 (2009) 8833.
54. Y. Ge, A.P.F. Turner, Molecularly imprinted sorbent assays: recent developments and applications, Chem. Eur. J., 2009, in press.
55. A.A. Özcan, R. Say, A. Denizli, A. Ersöz, L-histidine imprinted synthetic receptor for biochromatography applications, Anal. Chem., 78 (2006) 7253.
56. G. Baydemir, M. Andaç, N. Bereli, R. Say, A. Denizli, Selective removal of bilirubin from human p l a s m a with bilirubin imprinted particles, Ind. Eng. Chem. Res., 46 (2007) 2843.
57. M.L. Yarmush, K.P. Antonsen, S. Sundaram, D.M. Yarmush, Immunoadsorption: strategies for antigen elution and production of resuable adsorbents, Biotechnol. Prog., 8 (1992) 168.
58. M.J. Syu, J.H. Deng, Y.M. Nian, T.C. Chiu, A.H. Wu, Binding specificity of a-bilirubin-imprinted poly(methacrylic acid-co-ethylene glycol dimethylacrylate) toward a-bilirubin, Biomaterials, 26 (2005) 4684.
59. M.J. Syu, Y.M. Nian, Y.S. Chang, X.Z. Lin, S. C. Shiesh, Ionic effect on the binding of bilirubin to the imprinted poly(MAA-EGDMA), J. Chromatogr. A., 1122 (2006) 54.
60. Y. Yang, Y. Long, Q. Cao, K. Li, F. Liu, Molecularly imprinted polymer using b-cyclodextrin as functional monomer for the efficient recognition of bilirubin, Anal. Chim. Acta, 606 (2008) 92.
61. A.H. Wu, M.J. Syu, Synthesis of bilirubin imprinted polymer thin film for the continuous detection of bilirubin in an MIP/QCM/FIA system, Biosens. Bioelectron., 21 (2006) 2345.
62. M.J. Syu, Y.M. Nian, An allosteric method for the binding of bilirubin to the bilirubin imprinted poly(MAA-EGDMA), Anal. Chim. Acta, 539 (2005) 97.
63. M.J. Syu, J.H. Deng, Y.M. Nian, Towards bilirubin imprinted poly(MAA-EGDMA) for the specific binding of a-bilirubin, Anal. Chim. Acta, 504 (2004) 167.
64. G. Baydemir, N. Bereli, M. Andaç, I.Y. Galaev, R. Say, A. Denizli, Bilirubin recognition via molecularly imprinted supermacroporous cryogels, Colloids and Surfaces B., 68 (2009) 33.
65. G. Baydemir, N. Bereli, M. Andaç, I.Y. Galaev, R. Say, A. Supermacroporous PHEMA based cryogel with embedded bilirubin imprinted particles, React. Functl. Polym., 69 (2009) 36.
66. H.E., Stokinger, in: G.D. Clayton, and F.E. Clayton, (Eds.), Patty’s Industrial Hygiene and Toxicology, New York, John Wiley, 1981.
67. L. Friberg, C.G. Elinder, in: Encylopedia of Occupational Health and Safety, 3rd ed., Genewa, Switzerland, International Labor Organization, 1985.
68. L. Friberg, M. Piscator, G.F. Nordberg, T. Kjellstrom, Cadmium in the Environment, 2nd ed., Cleveland, CRC Press, 1974.
69. A. Denizli, Preparation of immunoaffinity membranes for cholesterol removal from human plasma, J. Chromatogr. B, 772 (2002) 357.
70. S. Margel, J. Hirsh, Hemoperfusion for detoxification of mercury. a model: treatment of severe mercury poisoning by encapsulated chelating spheres, Biomat. Med. Dev. Art. Org., 9 (1981) 107.
71. D. Horowitz, S. Margel, T. Shimoni, Iron detoxification by haemoperfusion through deferoxamine conjugated agarose-polyacrolein microsphere beads, Biomaterials, 6 (1985) 9.
72. M. Nordberg, Metallothioneins: historical review and state of knowledge, Talanta, 46 (1998) 243.
73. A.K.M. Kabzinski, Application of solid-phase extraction to the preconcentration of metallothionein and metals from physiological fluids, J. Chromatogr. A., 766 (1997) 121.
74. E.H. Ibrahim, A. Denizli, S. Bektas, O. Genc, E. Piskin, Cadmium removal from human plasma by Cibacron Blue F3GA and thionein incorporated into polymeric microspheres, J. Chromatogr. B., 720 (1998) 217.
75. F. Denizli, A. Denizli, Removal of cadmium(II) ions from human plasma by thionein modified pHEMA based membranes, React. Functl. Polym., 44 (2000) 207.
76. A. Denizli, H. Yavuz, Ç. Arpa, S. Bektaş, Ö. Genç, Cysteinylhexapeptide attached PHEMA beads for Cd(II) removal from human plasma in a packed-bed column, Sep. Sci. Technol., 38 (2003) 1869.
77. J.L. Brash, T.A. Horbett, (eds) Proteins at Interfaces: Physicochemical and Biochemical Studies, A.C.S., Washington DC, 1987.
78. A. Denizli, Heparin immobilized poly(2-hydroxyethyl methacrylate) based microspheres, J. Appl. Polym. Sci., 74 (1999) 655.
79. Y.F. Missirlis, W. Lemm, Modern Aspects of Protein Adsorption on Biomaterials, Kluwer Academic Publ., Dordrecht, 1990.
80. R.R. Crichton, Inorganic Biochemistry of Iron Metabolism, Ellis Horwood Limited, UK (1991).
81. J.M. Arena, Poisoning, Thomas Springfield, Illinois (1970).
82. R.B. Martin, The chemistry of aluminum as related to biology and medicine, Clin. Chem., 32 (1986) 1797.
83. T.L. Litovitz, B.F. Schmitz, N. Matyunas, T.G. Martin, 1987 annual report of the American Association of Poison Control Centers National Data Collection System, Am. J. Emerg. Med., 6 (1988) 479.
84. J.R. Mahoney, P.E. Hallway, B.E. Hedlund, J.W. Eaton, Acute iron poisoning. Rescue with macromolecular chelators, Am. Soc. Clin. Invest., 84 (1989) 1362.
85. C. Hershko, Iron chelators in medicine, Molec. Aspects. Med., 13 (1992) 113.
86. A. Jacobs, Iron chelation therapy for iron loaded patients, Br. J. Haematol., 43 (1979) 1.
87. C.F. Whitten, G.F. Gibson, M.H. Good, J.F. Goodwin, A.J. Brough, Studies in acute iron poisoning. I. Desferrioxamine in the treatment of acute iron poisoning: clinical observations, experimental studies, and theoretical considerations, Pediatrics, 36 (1965) 322.
88. A. Denizli, B. Salih, E. Piskin, New chelate-forming polymer microspheres carrying dyes as chelators for iron overload, J. Biomater. Sci. Polym. Ed., 9 (1998) 175.
89. H. Yavuz, Y. Arıca, A. Denizli, Therapeutic affinity adsorption of iron(III) with dye- and ferritin immobilized PHEMA adsorbent, J. Appl. Polym. Sci., 82 (2001) 186.
90. E.C. Thiel, Ferritin: Structure, gene regulation, and cellular function in animals, plants, and microorganisms, Annu. Rev. Biochem., 56 (1987) 289.
91. A. Treffry, S.H. Banyard, R.J. Hoare and P.M. Harrison, in: Proteins of Iron Metabolism, E.B. Brown, P. Aisen, J. Fielding and R.R. Crichton, eds., Grune & Stratton, New York, 1977.
92. A.H. Demirçelik, M. Andaç, C.A. Andaç, R. Say, A. Denizli, Molecular recognition- based detoxification of aluminum in human plasma, J. Biomat. Sci. Polym. Ed., 20 (2009) 1235.
93. L. Jia, L. Yang, H. Zou, Y. Zhang, J. Zhao, C. Fan, L. Sha, Protein A tangential flow affinity m e m b r a n e cartridge for extracorporeal immunoadsorption therapy, Biomed. Chromatogr., 13 (1999) 472.
94. Y. Minagawa, T. Kawakami, T. Kojima, Experiment of long term intermittent plasmapheresis for myasthenia gravis, Jpn. J. Artif. Organs, 12 (1983) 101.
95. T. Sato, M. Anno, K. Arai, N. Yamawaki, T. Kuroda, K. Inagaki, In vitro removal of anti-acetylcholine receptor antibodies with a new immunoadsorbent in sera from myasthenia gravis patients. Prog. Artif. Organs, 4 (1983) 719.
96. C. Freiberghaus, L.A. Larsson, S.B. Sundqvist, I.M. Nilsson, H. Thysell, T. Lindholm, A summary of five years clinical experience with extensive removal of immunoglobulins, Plasma Ther. Transfus. Technol., 7 (1986) 545.
97. W.O. Richter, M.G. Donner, A. Selmaier, E. Hiller, P. Schwandt, Efficacy and safety of immunoglobulin apheresis, ASAIO I, 43 (1997) 53.
98. I.M. Nilsson, E. Berntorp, O. Zettervall, Induction of split tolerance and clinical cure in high-responding hemophiliacs with factor IX antibodies, Proc. Natl. Acad. Sci USA, 83 (1986) 9169.